RWM
AKYA

Rialto Wealth Management’s Akoya BioSciences AKYA Stock Holding History

Rialto Wealth Management’s Portfolio AKYA Stock Details AKYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-298
Closed -$415 – 1704
2025
Q1 		$415 Buy
+298
New +$652 ﹤0.01% 968

Other funds holding AKYA

BWLSA
Blue Water Life Science Advisors Larkspur, California $125M AUM 91.82% 1-Year Est. Return
OBAM
ODDO BHF Asset Management Paris, France $2.54B AUM 41.83% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAPAIJV
Paragon Associates & Paragon Associates II Joint Venture Dallas, Texas $73.6M AUM 61.93% 1-Year Est. Return
TC
Trium Capital London, United Kingdom $163M AUM 45.8% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PCA
Peddock Capital Advisors Braintree, Massachusetts $501M AUM 29.8% 1-Year Est. Return
ECM
ExodusPoint Capital Management New York $12.6B AUM 30.13% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Rialto Wealth Management's AKYA Position: Q2 2025 in Review

Rialto Wealth Management sold out of Akoya BioSciences (AKYA) in Q2 2025, closing a stake of 298 shares — an estimated $415 sold.

Rialto Wealth Management first reported a position in AKYA in Q1 2025 and held it in 1 quarter. The position peaked at $415 in Q1 2025. 58 funds tracked by Wall St. Rank hold AKYA as of Q2 2025.

  • Rialto Wealth Management reported no remaining Akoya BioSciences position as of Q2 2025 after selling out during the quarter.
  • Rialto Wealth Management sold 298 Akoya BioSciences shares in Q2 2025, an estimated $415.
  • Rialto Wealth Management first reported a position in Akoya BioSciences in Q1 2025 and held it in 1 quarter.
  • Rialto Wealth Management's Akoya BioSciences position peaked at $415 in Q1 2025.
  • 58 funds tracked by Wall St. Rank held Akoya BioSciences as of Q2 2025.

Based on Rialto Wealth Management's 13F filing for Q2 2025, filed 6 Aug 2025.